- Home
- »
- Medical Devices
- »
-
Remote Patient Monitoring System Market Report, 2026-2033GVR Report cover
Remote Patient Monitoring System Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Vital Sign Monitor, Special Monitors), By Application (Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder), By End Use, By Region, And Segment Forecasts
Market Size, 2025
$26.0BMarket Estimate, 2026
$30.9BMarket Forecast, 2033
$110.7BCAGR, 2026–2033
20.0%Remote Patient Monitoring System Market Summary
The global remote patient monitoring system market size was valued at USD 26.0 billion in 2025 and is projected to grow from USD 30.9 billion in 2026 to USD 110.7 billion by 2033, at a CAGR of 20.0% from 2026 to 2033. The market in North America dominated with a revenue share of 40.4% in 2025. The global market growth is driven by the increasing prevalence of chronic diseases, rising adoption of telehealth and digital health platforms, technological advancements in wearable and connected devices, and growing preference for home healthcare and remote care services.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By product: Special monitors segment held the largest market share of 89.7% in 2025.
- By application: Diabetes segment held the largest market share of 13.7% in 2025.
- By end use: Hospital-based patient segment held the largest market share in 2025.
Regional Highlights
- Largest regional market: North America (40.4% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
- By country: Germany held the largest market share in 2025
Market Size & Forecast
- Market size in 2025: USD 26.0 Billion
- Estimated market size in 2026: USD 30.9 Billion
- Projected market size by 2033: USD 110.7 Billion
- CAGR (2026-2033): 20.0%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
To learn more about this report,Download Free Sample Report
Market Dynamics
The rising adoption of telehealth and digital health platforms is significantly driving market growth. Healthcare providers are increasingly integrating remote patient monitoring technologies with telemedicine platforms to enable real-time patient tracking, virtual consultations, and continuous disease management outside traditional clinical settings. The growing demand for accessible and cost-effective healthcare services, particularly following the COVID-19 pandemic, has accelerated the adoption of connected healthcare ecosystems globally. Remote patient monitoring systems support physicians in tracking patient vitals remotely, improving treatment adherence, and reducing hospital readmissions, thereby strengthening the shift toward digital healthcare delivery models.
In addition, increasing collaboration among healthcare stakeholders to enhance patient monitoring programs is expected to further propel market growth. For instance, in August 2023, EPIC Health and OMRON Healthcare collaborated to address health inequities in Detroit, U.S. Under this partnership, OMRON Healthcare deployed its VitalSight remote patient monitoring service to support the diagnosis and management of patients with hypertension.
The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, hypertension, chronic obstructive pulmonary disease (COPD), and cancer drives the market growth. Chronic conditions require continuous monitoring and long-term disease management, thereby increasing the demand for remote patient monitoring solutions. According to the World Health Organization 2025 report, cardiovascular diseases accounted for nearly 19 million deaths globally in 2021, followed by cancers with 10 million deaths and chronic respiratory diseases with 4 million deaths.
In addition, the International Diabetes Federation estimated that nearly 537 million adults were living with diabetes globally in 2021, and the number is projected to reach 643 million by 2030. Remote patient monitoring system assist healthcare providers track patient vitals in real time, reduce hospital readmissions, and improving treatment adherence. The growing burden of chronic diseases, particularly among the aging population, is significantly accelerating the adoption of connected monitoring technologies across hospitals and home healthcare settings.
The rapid advancement and integration of artificial intelligence (AI), Internet of Things (IoT), and 5G connectivity present a strong growth opportunity for the Remote Patient Monitoring (RPM) systems market. These technologies enable real-time, high-speed transmission of large volumes of patient health data, thereby improving the accuracy, responsiveness, and efficiency of remote monitoring systems. AI-driven analytics support predictive healthcare by identifying early warning signs of disease deterioration, while IoT-enabled wearable devices ensure continuous and automated data collection.
AI is further transforming RPM by enabling continuous, real-time analysis of biometric data from connected devices such as blood pressure monitors, pulse oximeters, and glucose monitors through advanced algorithms and machine learning capabilities. According to IQVIA, by 2030, over 142 million patients in the U.S., nearly 40% of the population, are expected to use RPM technologies, highlighting the rapid adoption of digital health solutions.
Moreover, the rollout of 5G networks further enhances connectivity, reducing latency and enabling seamless communication between patients and healthcare providers. Together, these technological advancements are creating a highly connected digital healthcare ecosystem, significantly boosting the adoption of remote patient monitoring solutions globally.
Market Concentration & Characteristics
The degree of innovation in the remote patient monitoring systems market is high, driven by rapid advancements in digital health technologies, increasing investments in healthcare IT infrastructure, and the growing integration of artificial intelligence (AI) and machine learning. In addition, the adoption of IoT-enabled wearable devices and cloud-based platforms is further enhancing remote monitoring capabilities and improving clinical decision-making. For instance, in January 2026, LiverRight announced the launch of a contactless remote patient monitoring (RPM) solution integrated into its telemedicine platform. The system uses in-call camera-based technology to capture real-time patient vital parameters such as heart rate, breathing rate, and blood pressure without requiring any wearable devices. This innovation aims to improve accessibility, reduce device dependency, and enhance early detection of liver-related conditions such as jaundice.
To learn more about this report,Download Free Sample Report
"Partners like LiverRight have every chance to move the average stage of diagnosis in chronic diseases far earlier, Telemedicine is becoming more mainstream but the health monitoring tools simply haven't caught up. In most video visits today, the alternative to something like Wise AI is that clinicians must rely on self-reported symptoms, guesswork, or a consumer device if the patient happens to own and use one. We're building the infrastructure for contactless health monitoring inside video visits, delivering longitudinal, device-free metrics that improve care quality while dramatically reducing the cost and complexity of traditional RPM."
- Annanya Panagala, CEO of Wise AI.
The level of partnerships & collaboration activities by key players in the industry is high with major players joining forces to enhance technological capabilities, broaden product offerings, and streamline global access to advanced monitoring solutions. For instance, in March 2025, Circadian Health and Tenovi partnered to integrate Tenovi’s RPM platform into Circadian’s chronic disease management programs, using connected devices such as blood pressure monitors and weight scales alongside medication adherence tracking to enhance remote patient support.
The impact of regulations in the remote patient monitoring systems industry is high, as healthcare providers are required to comply with stringent data privacy, security, and interoperability standards. Regulations such as HIPAA in the U.S., GDPR in Europe, and other regional frameworks mandate the secure collection, storage, and sharing of patient health information. In addition, regulatory bodies promoting the adoption of electronic health records (EHRs) and value-based care models further underscore the need for standardized and interoperable digital healthcare infrastructure, thereby shaping the development and deployment of remote patient monitoring solutions.
Regional expansion in the remote patient monitoring systems industry is moderate to high, as healthcare systems worldwide increasingly recognize the importance of centralized and interoperable data platforms. North America and Europe currently lead the market due to advanced healthcare infrastructure, strong digital health adoption, and supportive regulatory frameworks. Meanwhile, emerging regions such as Asia-Pacific, Latin America, and the Middle East are witnessing rapid adoption of digital health technologies, driven by improving healthcare infrastructure, rising chronic disease burden, and increasing government initiatives to promote telehealth and remote care solutions.
Product Insights
The special monitors segment led the market and accounted for 89.7% revenue share in 2025, owing to its ability to monitor clinically important parameters pre- and post-surgery, identify symptoms early, and prevent complications. Advanced features such as wireless communication and iPad connectivity allow early diagnosis and higher applicability of the products. Vital sign monitors can effectively track a patient's ECG, noninvasive blood pressure, body temperature, respiration rate, and brain activity. Integration of more than one vital sign monitor in a single system is expected to boost the popularity of these products, thereby leading to increased adoption during the forecast period.
Vital sign monitors segment is expected to witness the fastest CAGR of 22.8% from 2026 to 2033. Heart rate monitor is identified as the dominating product sub-segment due to the increasing incidence of cardiac conditions globally. The surge in the number of individuals with heart disorders has led to the increased usage of these monitors. For instance, in November 2022, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched VS9, a vital sign monitoring device. The device can perform multifaceted functions, including non-invasive blood pressure, pulse oximetry, and temperature measurements.
Application Insights
Diabetes emerged as the leading segment in 2025, accounting for a 13.7% market share. Diabetes is one of the major chronic diseases globally and requires continuous monitoring of blood glucose levels for effective disease management. It can adversely affect multiple body functions, including cardiac activity, vision, liver function, and renal function. As a result, continuous and routine monitoring is essential in diabetes care, which can be efficiently achieved through remote patient monitoring systems, supporting better glycemic control and reducing the risk of complications.
The cardiovascular diseases application segment is also expected to witness significant growth over the forecast period. Hypertension significantly increases the risk of developing cardiovascular diseases, making continuous monitoring essential for early intervention and effective disease management. According to the World Health Organization (2025), over 1.4 billion adults aged 30-79 years were living with hypertension in 2024. Remote patient monitoring plays a key role in controlling blood pressure levels and reducing the risk of complications associated with cardiovascular conditions.
End Use Insights
The hospital-based patient segment led the market in 2025. Hospitals cater to a large number of both outpatients and inpatients, offering a wide range of diagnostic services supported by a skilled clinical workforce. The large patient pool and the increasing volume of diagnostic and monitoring procedures are key factors driving segment growth. In addition, hospitals are increasingly adopting advanced remote patient monitoring solutions to enhance care delivery and operational efficiency. For instance, in June 2024, Masimo collaborated with Cleveland Clinic to enhance hospital-based remote patient monitoring through the integration of AI-powered monitoring and automation platforms, aimed at improving real-time patient surveillance and early detection of clinical deterioration.
To learn more about this report,Download Free Sample Report
Home healthcare is anticipated to exhibit the fastest CAGR over the forecast period. The cost-efficiency of this alternative care setting, along with the availability of qualified healthcare resources, is expected to support segment growth. Considering the increasing strain on hospital resources and personnel, remote patient monitoring presents significant opportunities for market players to partner with healthcare providers and launch innovative solutions that enable affordable and effective care at patients’ homes. In addition, the COVID-19 pandemic significantly increased the number of patients interacting with healthcare professionals from home, further boosting the adoption of remote patient monitoring systems.
Regional Insights
North America Remote Patient Monitoring Systems Market Trends
North America dominated the remote patient monitoring systems market, accounting for a revenue share of 40.4% in 2025. The region’s growth is primarily driven by the rising incidence of chronic diseases, increasing demand for wireless and portable monitoring systems, and the presence of well-established reimbursement frameworks that reduce out-of-pocket healthcare expenditure. In addition, strong adoption of digital health technologies, advanced healthcare infrastructure, and the presence of leading market players further support the region’s dominance in the RPM market.
To learn more about this report,Download Free Sample Report
U.S. Remote Patient Monitoring Systems Market Trends
Remote patient monitoring systems market in the U.S. is experiencing strong growth driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and heart failure, along with a rapidly aging population requiring continuous care. Increased adoption of telehealth, supportive reimbursement policies, and the shift towards value-based care models have accelerated RPM integration across hospitals, homecare settings, and outpatient facilities.
Europe Remote Patient Monitoring Systems Market Trends
Remote patient monitoring systems market in Europe is expected to remain the second-largest revenue-generating region over the forecast period. The regional growth is driven by the rising burden of chronic diseases, higher mortality rates, and increasing demand for cost-effective treatment options. In addition, the growing adoption of in-home monitoring solutions, well-established central data management systems, and continuous improvements in the accuracy and efficiency of remote patient monitoring devices are key factors supporting market growth across the region.
Remote patient monitoring systems market in UK is growing focus on reducing hospital pressures and managing long-term conditions is accelerating the adoption of remote patient monitoring (RPM) systems. The National Health Service (NHS) is actively promoting digital care pathways, with RPM playing a central role in supporting patients with conditions such as COPD, heart failure, and diabetes. NHS England’s Virtual Wards initiative has provided a formal structure for remote monitoring, aiming to treat patients safely at home while freeing up hospital beds.
Remote patient monitoring systems market in Germany is expected to grow significantly over the forecast period, owing to the rising prevalence of chronic conditions and the need for long-term outpatient care are key drivers for remote patient monitoring (RPM) adoption. Healthcare providers are increasingly relying on RPM tools to manage patients with heart failure, diabetes, and COPD outside traditional clinical settings. These systems reduce avoidable hospital admissions and support early intervention through continuous data capture. With a healthcare model that emphasizes preventive care and patient self-management, RPM fits well into existing care pathways.
Asia Pacific Remote Patient Monitoring Systems Market Trends
Asia Pacific is expected to grow at the fastest CAGR from 2026 to 2033, driven by significant untapped opportunities in emerging markets such as India and China. The expansion of mobile connectivity and increasing smartphone penetration have enhanced the feasibility of deploying remote patient monitoring (RPM) systems across diverse patient populations. This digital infrastructure growth is further supporting the adoption of connected healthcare solutions across the region. For instance, in May 2024, BM Birla Heart Hospital in India partnered with Dozee to implement AI-powered connected beds for continuous remote patient monitoring in cardiac wards, enabling real-time patient tracking and improved clinical efficiency.
Remote patient monitoring systems market in China is expected to grow very fast due to the rising prevalence of chronic diseases and a rapidly aging population, driving greater interest in remote patient monitoring (RPM) systems. RPM solutions are being adopted to reduce hospital congestion and extend healthcare services to under-resourced rural areas. In addition, government initiatives promoting digital health and telemedicine are supporting the wider deployment of connected care technologies. Furthermore, China’s strong domestic technology ecosystem is enabling the rapid development and adoption of advanced remote monitoring platforms.
Remote patient monitoring systems market in India is growing as healthcare infrastructure continues to improve, RPM is increasingly becoming a key component of India’s evolving healthcare delivery models. For instance, in February 2025, Kauvery Hospital Group’s investment arm, Healthcare Capital, made an undisclosed investment in Lifesigns, a company specializing in AI-driven remote patient monitoring solutions that provide predictive alerts and real-time clinical insights. The funding is aimed at strengthening its AI algorithms, supporting new product development, and accelerating overall expansion initiatives.
Latin America Remote Patient Monitoring Systems Market Trends
The growing prevalence of chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders is pushing healthcare systems in Latin America to explore remote patient monitoring systems. RPM offers a scalable solution to extend care access across geographically dispersed and underserved regions. Increasing urban-rural health disparities have made continuous, remote care particularly relevant for improving outcomes.
Middle East & Africa Remote Patient Monitoring Systems Market Trends
Healthcare systems across the Middle East and Africa are increasingly turning to remote patient monitoring systems to address access gaps and infrastructure challenges. In regions with physician shortages and limited specialist coverage, RPM is emerging as a tool to extend care beyond urban hospitals. Rising incidence of chronic diseases is prompting governments to explore technology-driven care models.
Key Remote Patient Monitoring Systems Company Insights
The market is highly fragmented, with both small and large players operating in the space, leading to intense competition, particularly among smaller companies striving to sustain their market position. Strategies such as new product launches and strategic partnerships are playing a key role in driving market growth.
Key Remote Patient Monitoring System Companies:
The following key companies have been profiled for this study on the remote patient monitoring system market.
-
Koninklijke Philips N.V.
-
Medtronic
-
Abbott
-
Masimo
-
GE HealthCare
-
Nihon Kohden Corporation
-
Omron Corporation
-
Boston Scientific Corporation
-
Dräger Medical (part of Drägerwerk AG group)
-
Biotronik
-
Mindray
-
Welch Allyn (Baxter International)
-
Smiths Medical (acquired by ICU Medical Inc.)
Competitive Benchmarking
Operating Strategies
Competitive Edge
Weaknesses
Mature Player: Koninklijke Philips N.V
- Focus on integrated ecosystem offerings combining RPM devices, software, and hospital solutions.
- Strong emphasis on strategic partnerships with hospitals, health systems, and telehealth providers globally.
- Established global brand presence with strong regulatory approvals and trust in clinical settings.
- Advanced R&D capabilities enabling continuous innovation in AI-driven and connected monitoring technologies.
- High product pricing limits adoption in cost-sensitive and emerging markets.
- Slower decision-making and longer product development cycles compared to agile competitors.
Emerging Player: Mindray
- Target cost-sensitive and high-growth markets, especially in Asia-Pacific and developing regions.
- Competitive pricing and flexibility in product customization.
- Limited global distribution networks compared to established multinational players.
Recent developments
-
In February 2026, Lord’s Mark Industries launched an AI-based contactless remote patient monitoring system at Gauhati Medical College and Hospital, enabling real-time patient tracking while reducing infection risks in ICU settings.
-
In September 2025, HealthSnap partnered with Sentara Health to launch an enterprise remote patient monitoring (RPM) and chronic care management (CCM) program across its network. The initiative aims to scale proactive chronic disease management for conditions such as hypertension, diabetes, and heart failure by leveraging digital monitoring platforms to improve patient outcomes and enable continuous care outside clinical settings.
“This partnership with HealthSnap represents significant progress in Sentara’s mission to improve health and wellbeing in the communities we serve. Pairing innovations in technology and care delivery enables Sentara clinicians to proactively address chronic conditions-an aim which has been limited by traditional care delivery models. Maintaining a patient-centric approach, coordinated care teams will facilitate improved health behaviors and timely interventions between clinic visits using HealthSnap’s platform.”
- Dr. Kara Hawkins, MS, medical director, Sentara ambulatory remote patient monitoring program.
-
In April 2025 Validic partnered with Tenovi to enhance remote patient monitoring through the integration of Tenovi’s cellular-connected medical devices with Validic’s EHR-integrated platform.
“Every person deserves access to affordable, quality healthcare enabled by advanced digital health solutions, regardless of their location or economic status. This integration enables health systems to deliver personalized, proactive care more effectively, without adding workflow burden or requiring patients to navigate complex technology”.
- said Drew Schiller, CEO and Co-founder of Validic
-
In Janauary 2025, Smart Meter expanded its RPM footprint by integrating its iBloodPressure Classic, iGlucose cellular meters, and SmartTouch platform into over 350,000 patient setups, supported by a new 25,000 sq. ft. Tampa facility and a growing EHR integration with eClinicalWorks.
“We are grateful to our 900 SmartPartners across the US who entrust us with delivering millions of vital sign readings to their platforms and their providers for better patient care.”
- Casey Pittock, CEO.
-
In September 2024, Veridian acquired Zewa to strengthen its respiratory and RPM device portfolio, gaining products like nebulizers, oximeters, and connected BP monitors.
“This combination expands Veridian's RPM, consumer medical product portfolio, and telehealth segments positioning the company as a leading supplier in the diagnostic medical and telehealth product categories in North America. Veridian will benefit from Zewa's technology capabilities and diverse product line, providing additional product solutions to its customers."
- John Aldridge, Chief Digital Health Officer of Veridian.
-
In December 2023, CoachCare acquired Verustat to expand its remote patient monitoring (RPM) footprint, integrating Verustat's primary care and cardiology-focused services.
“We have gotten to know the Verustat team over the past year and their approach to remote care aligns well with CoachCare. We are pleased to welcome their clients and staff to CoachCare and to continue growing our best in class remote care platform.”
- Wes Haydon, President and Co-Founder of CoachCare. “
Remote Patient Monitoring Systems Market Report Scope
Report Attribute
Details
Market size in 2025
USD 26.0 billion
Estimated market size in 2026
USD 30.9 billion
Projected market size by 2033
USD 110.7 billion
Growth rate
CAGR of 20.0% from 2026 to 2033
Actual data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, application, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Koninklijke Philips N.V.; Medtronic; Abbott; Masimo; GE HealthCare; Nihon Kohden Corporation; Omron Corporation; Boston Scientific Corporation; Dräger Medical (part of Drägerwerk AG group); Biotronik; Mindray; Welch Allyn (acquired by Hillrom; now part of Baxter International); Smiths Medical (acquired by ICU Medical Inc.)
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Remote Patient Monitoring System Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global remote patient monitoring systems market report based on product, application, end use, and region:
To learn more about this report,Download Free Sample Report
-
Product Outlook (Revenue, USD Billion, 2021 - 2033)
-
Vital Sign Monitors
-
Blood Pressure Monitors
-
Pulse Oximeters
-
Heart Rate Monitor (ECG)
-
Temperature Monitor
-
Respiratory Rate Monitor
-
Capnographs
-
Spirometers
-
-
Brain Monitoring (EEG)
-
-
Special Monitors
-
Anesthesia Monitors
-
Blood Glucose Monitors
-
Cardiac Rhythm Monitor
-
Respiratory Monitor
-
Fetal Heart Monitors
-
Prothrombin Monitors
-
Multi Parameter Monitors (MPM)
-
Others
-
-
-
Application Outlook (Revenue, USD Billion, 2021 - 2033)
-
Cancer
-
Cardiovascular Diseases
-
Diabetes
-
Sleep Disorder
-
Weight Management and Fitness Monitoring
-
Bronchitis
-
Infections
-
Eye infections
-
Sinus Infections
-
Strep Throat
-
-
Virus
-
Dehydration
-
Hypertension
-
-
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
-
Hospital-Based Patients
-
Ambulatory Patients
-
Home Healthcare
-
-
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Segmentation analysis by product, application, end-use, and region.
Delivered detailed segmentation of the remote patient monitoring devices market by product type, application areas, end-user categories, and regional breakdown across key geographies.
Helps identify leading market participants, evaluate competitive positioning, and assess regional business strength across the remote patient monitoring system market.
Technology and innovation analysis (AI, IoT, wearable integration)
Delivered insights on technological advancements including AI-enabled monitoring, IoT-based devices, cloud integration, and 5G-enabled healthcare systems.
Helps understand innovation pipeline and future market transformation trends.
Competitive landscape and strategic developments
Delivered detailed profiling of key and emerging players, including company-wise market share analysis, strategic initiatives, partnerships, and recent mergers and acquisitions (top M&A deals included)
Supports competitive benchmarking and helps track market consolidation, strategic movements, and investment opportunities.
Frequently Asked Questions About This Report
The global remote patient monitoring system market size was valued at USD 26.0 billion in 2025 and is estimated at USD 30.9 billion for 2026.
Asia Pacific is the fastest-growing region over the forecast period.
The hospital-based patient segment held the largest revenue share in 2025, while home healthcare is the fastest-growing segment.
Key players include Koninklijke Philips N.V.; Medtronic; Abbott; Masimo; GE HealthCare; Nihon Kohden Corporation; Omron Corporation; Boston Scientific Corporation; Dräger Medical (part of Drägerwerk AG group); Biotronik; Mindray; Welch Allyn (acquired by Hillrom; now part of Baxter International); Smiths Medical (acquired by ICU Medical Inc.)
The global remote patient monitoring system market is expected to grow at a CAGR of 20.0% from 2026 to 2033, reaching USD 110.7 billion by 2033.
North America dominated the remote patient monitoring system market with a share of 40.4% in 2025. This is attributable to the increasing geriatric population, the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of a sophisticated reimbursement structure aimed at cutting out-of-pocket expenditure levels.
Key factors that are driving the RPM system market growth include increasing prevalence of chronic diseases, rising adoption of telehealth and digital health platforms, technological advancements in wearable and connected devices, and growing preference for home healthcare and remote care services.
The special monitors segment led with a 89.7% revenue share in 2025, while vital sign monitors is the fastest-growing product.
The diabetes segment accounted for the largest revenue share of 13.7% in 2025, while the cardiovascular diseases is a significantly growing application.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.